29 Firmen mit Ergebnissen für "immunotherapy com com com"

University of Zurich

https://www.campus-schlieren.uzh.ch/en.html  

8952 Schlieren, Wagistrasse 12

The University of Zurich (UZH) is Switzerland’s largest university, with seven faculties and a current enrollment of over 26,000 students. More than 5,000 highly qualified members of the teaching staff, including some 580 professors, teach and conduct research at the 150 University institutes. In the field of life sciences, the University of Zurich is well known for its groundbreaking research in medicine, immunology, neuroscience, and structural biology. In the interest of serving the community, the University of Zurich promotes the transfer of research-based knowledge to private enterprise, and our spin-off ventures and business partnerships regularly lead to the creation of attractive jobs in innovative fields.

University of Zurich

Wagistrasse 12

8952 Schlieren

649 Ergebnisse für "immunotherapy com com com" unter University of Zurich

UZH - URPP Dynamics of Healthy Aging - Dipl. rer. com. Susanne Nieke

... Susanne Nieke, Dipl. rer. com. Wissenschaftliche Mitarbeiterin ... UZH - URPP Dynamics of Healthy Aging - Dipl. rer. com. Susanne Nieke ... UZH - URPP Dynamics of Healthy Aging - Dipl. rer. com. Susanne Nieke Home Main navigation Search ... UZH - URPP Dynamics of Healthy Aging - Dipl. rer. com. Susanne Nieke ...

Mehr Ergebnisse

ETH Entrepreneurship

https://ethz.ch/en/industry/entrepreneurship.html  

8952 Schlieren, Wagistrasse 18


 entrepreneurship@ethz.ch

Excellence in entrepreneurship at ETH Zurich is driven by world-​class research and education. It gives rise to groundbreaking new ventures that consolidate Switzerland’s technological leadership. Are you an aspiring entrepreneur seeking to find solutions to global challenges and create a better future for humanity. Or are you just interested in the entrepreneurial ecosystem at ETH Zurich? Browse our websites to find out more or reach out to the Entrepreneurship group, if you have any questions. 

ETH Entrepreneurship

Wagistrasse 18

8952 Schlieren

Somagenetix

https://www.wysszurich.ch/projects/somagenetix  

8952 Schlieren, Wagistrasse 23

Gene therapy solutions for patients with severe inherited diseases.

Somagenetix

Wagistrasse 23

8952 Schlieren

Virometix AG

http://virometix.com  

8952 Schlieren, Wagistrasse 14

 +41 (0)43 433 86 60
 info@virometix.com

Virometix AG is a privately held biotechnology company developing a new generation of vaccines and immunotherapeutic drugs for the prevention and treatment of infectious and chronic human diseases.

Virometix AG

Wagistrasse 14

8952 Schlieren

5 Ergebnisse für "immunotherapy com com com" unter Virometix AG

Newsroom - Virometix AG

... Research Collaboration to Use Synthetic Virus-Like Particles for Ultra-Fast Allergy Immunotherapy Study is ... immunotherapy, and Virometix AG, a company developing a new generation of vaccines and immunotherapeutic drugs ... August – 02 September 2022; https://www.eps2022. com/ ). With presentations on our T-cell epitope SARS-CoV ... Announce Research Collaboration to Use Synthetic Virus-Like Particles for Ultra-Fast Allergy Immunotherapy ...

Microsoft Word - 200709 Joint PR Anergis_Virometix_HZI_final_approv...

... Allergy Immunotherapy - Study is performed at the Helmholtz Centre for Infection Research and supported by ... Contiguous Overlapping Peptides (COPs) for ultra-fast allergy immunotherapy, and Virometix AG, a company ... Allergy Immunotherapy - Study is performed at the Helmholtz Centre for Infection Research and supported by ... Contiguous Overlapping Peptides (COPs) for ultra-fast allergy immunotherapy, and Virometix AG, a company ...

Mehr Ergebnisse

Roche Glycart AG

https://www.roche.ch/en/sites/schlieren  

8952 Schlieren, Wagistrasse 10

 +41 43 215 10 00

The mission of the Roche Innovation Center Zurich (RICZ) is to be a leader in developing new generations of engineered antibody products with increased efficacy that address unmet clinical needs. The RICZ site is also the Center of Excellence in Cancer Immunotherapy within the Roche Group.

Roche Glycart AG

Wagistrasse 10

8952 Schlieren

177 Ergebnisse für "immunotherapy com com com" unter Roche Glycart AG

Roche - Immunotherapy at Roche

... Neuroscience Our approach to cancer immunotherapy Some people can point to a book that changed ... Immunotherapy Development at Roche. For decades, researchers trying to devise new treatments for cancer have ... Roche - Immunotherapy at Roche ... https://www.roche.com/research_and_development/what_we_are_working_on/oncology/cancer- immunotherapy ... Roche - Immunotherapy at Roche ...

Roche - Discover Roche’s latest innovations in cancer immunotherapy

... & Development You are here: Meet the scientists exploring new immunotherapy pathways in the battle against ... words, cancer immunotherapy aims to harness the power of the immune system to fight cancer. Like brakes ... Roche - Discover Roche’s latest innovations in cancer immunotherapy ... https://www.roche.com/research_and_development/what_we_are_working_on/oncology/cancer- immunotherapy ... Roche - Discover Roche’s latest innovations in cancer immunotherapy ...

Mehr Ergebnisse

University Hospital Zurich​, Research and Education Office

https://www.usz.ch/forschung/Seiten/default.aspx  

8091 Zürich, Rämistrasse 100

The University Hospital Zurich is one of Switzerland’s largest hospitals and a pioneering institution in the field of clinical research. In its 40 departments and institutes, it assembles and practices all medical disciplines and enjoys an excellent reputation for state-of-the-art medicine, professional and com- passionate patient care, and groundbreaking bench-to-bedside translational medical research.

University Hospital Zurich​, Research and Education Office

Rämistrasse 100

8091 Zürich

115 Ergebnisse für "immunotherapy com com com" unter University Hospital Zurich​, Research and Education Office

The updated Swiss guidelines 2016 for the treatment and follow-up o...

... subtypes [6] Superficial spreading melanoma (SSM) is the most com- mon subtype (70%) and is characterised ... of treatments, whether with small molecules or immunotherapy, one of the most important challenges ... subtypes [6] Superficial spreading melanoma (SSM) is the most com- mon subtype (70%) and is characterised ... of treatments, whether with small molecules or immunotherapy, one of the most important challenges ...

Research activities in Immunotherapy of the Department of Dermatolo...

... Kündig & Pål Johansen Main fields of research Our research focused on immunotherapy of allergies ... clinical studies in humans. In allergy, we aim to improve efficacy and safety of allergen immunotherapy ... Research activities in Immunotherapy of the Department of Dermatology – Universitätsspital Zürich ... https://new.usz.ch/fachbereich/dermatologie/forschung/ immunotherapy/ ... Research activities in Immunotherapy of the Department of Dermatology – Universitätsspital Zürich ...

Mehr Ergebnisse

Blutspende SRK Zürich

https://www.blutspendezuerich.ch/  

8952 Schlieren, Rütistrasse 19

 +41 58 272 52 52
 info@zhbsd.ch

The Zurich Blood Transfusion Service SRK (ZHBSD) is a nonprofit foundation and independent partner in the healthcare sector. It ensures the supply of blood and blood products to patients in the Zurich region. Our products are made exclusively from voluntary, unpaid blood donations. We offer our services at cost-covering prices and without government subsidies. Along with ten other regional blood donation services in Switzerland, we are a member of the Swiss Red Cross Blood Donation Service (BSD SRK AG).

Blutspende SRK Zürich

Rütistrasse 19

8952 Schlieren

68 Ergebnisse für "immunotherapy com com com" unter Blutspende SRK Zürich

Mapping naturally presented T cell antigens in medulloblastoma base...

... cell responses, supporting their potential for T cell immunotherapy. This study is an in-depth mapping ... prerequisite for T cell-based immunotherapy is the pre- sentation of tumor-associated peptides by human ... cell responses, supporting their potential for T cell immunotherapy. This study is an in-depth mapping ... prerequisite for T cell-based immunotherapy is the pre- sentation of tumor-associated peptides by human ...

untitled

... HSCs are com- mitted exclusively to their tissue of origin, namely the hematopoi- etic system. However ... , isolate and culture-expand tu- mor-targeting immune cells. Both basic and clinical research com- munities ... HSCs are com- mitted exclusively to their tissue of origin, namely the hematopoi- etic system. However ... , isolate and culture-expand tu- mor-targeting immune cells. Both basic and clinical research com- munities ...

Mehr Ergebnisse

ImmunOs Therapeutics AG

http://immunostherapeutics.com/  

8952 Schlieren, Wagistrasse 14


 info@immunostherapeutics.com

ImmunOs Therapeutics AG is a clinical-stage biotechnology company developing the next generation of novel immunotherapies that enhance the efficacy of market leading checkpoint inhibitors and costimulatory agonists for cancer therapy. The company is actively discussing and exploring new strategic collaborations with leading global pharmaceutical companies.

ImmunOs Therapeutics AG

Wagistrasse 14

8952 Schlieren

21 Ergebnisse für "immunotherapy com com com" unter ImmunOs Therapeutics AG

Background on Cancer Immunotherapy - Immunostherapy

... Contact Background on Cancer Immuno­therapy Current approaches in cancer immunotherapy focus mainly ... prevent T cells from eliminating cancer cells (checkpoint inhibitors). Cancer immunotherapy has been a ... Background on Cancer Immunotherapy - Immunostherapy ... https://www.immunostherapeutics.com/approach/background-on-cancer- immunotherapy/ ... Background on Cancer Immunotherapy - Immunostherapy ...

Investors | Immunos Therapeutics

... private investors. The Company has built a preclinical portfolio of novel immunotherapy candidates and is ... Company has built a preclinical portfolio of novel immunotherapy candidates and is currently exploring ...

Mehr Ergebnisse

Neurimmune Therapeutics AG

http://www.neurimmune.com  

8952 Schlieren, Wagistrasse 18

 +41 44 755 46 46
 info@neurimmune.com

Neurimmune is a biopharmaceutical company dedicated to the development of immunotherapeutics for the treatment and prevention of human disorders with a focus on protein aggregation diseases.

Neurimmune Therapeutics AG

Wagistrasse 18

8952 Schlieren

10 Ergebnisse für "immunotherapy com com com" unter Neurimmune Therapeutics AG

Neurimmune - Lab Insights: Immunotherapy for Type-2 diabetes

... All News and Press Releases Lab Insights: Immunotherapy for Type-2 diabetes Neurimmune is pursuing ... the development of an innovative antibody-based program for the immunotherapy of type-2 diabetes, and ... Neurimmune - Lab Insights: Immunotherapy for Type-2 diabetes ... http://www.neurimmune.com/stories/lab-insights- immunotherapy-for-type-2-diabetes.html ... Neurimmune - Lab Insights: Immunotherapy for Type-2 diabetes ...

Neurimmune - About Neurimmune

... exclusive rights to three immunotherapy programs with human monoclonal antibodies targeting alpha-synuclein ... executing an agreement granting worldwide exclusive rights to three immunotherapy programs with human ...

Mehr Ergebnisse

InSphero AG

http://www.insphero.com  

8952 Schlieren, Wagistrasse 27

 +41 44 515049-0
 info@insphero.com

InSphero is a leading supplier of organotypic, biological in vitro 3D microtissues for highly predictive drug testing. The company currently counts all of the top ten global pharmaceutical and cosmetics companies as customers and is helping them to implement its patented microtissue technology in their development work-flow.

InSphero AG

Wagistrasse 27

8952 Schlieren

7 Ergebnisse für "immunotherapy com com com" unter InSphero AG

... >  View latest Newsletters 04/2014 - ... href="http://us2.campaign-archive1. com/?u=12bba0b8698d7ada929228dd1&id=c6a20676cb&e=88dc08ae62 ... >  View latest Newsletters 04/2014 - ... href="http://us2.campaign-archive1. com/?u=12bba0b8698d7ada929228dd1&id=c6a20676cb&e=88dc08ae62 ...

Newsletter Archive

... >  View latest Newsletters 04/2014 - ... href="http://us2.campaign-archive1. com/?u=12bba0b8698d7ada929228dd1&id=c6a20676cb&e=88dc08ae62 ... >  View latest Newsletters 04/2014 - ... href="http://us2.campaign-archive1. com/?u=12bba0b8698d7ada929228dd1&id=c6a20676cb&e=88dc08ae62 ...

Mehr Ergebnisse

Mehr Firmen

Nach oben